JA
Josekutty Alumparambil Joseph
About Josekutty Alumparambil Joseph
Data last updated:
Josekutty Alumparambil Joseph is an Additional Director at Jk Clinical Research Services Private Limited (since 2024), Additional Director at Pharmalectin India Private Limited (since 2024) and Additional Director at Alke Research Private Limited (since 2024). The companies operate in Software, Chemicals and Pharma.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 31 May 2024 | 2024 | Active | ||
| Additional Director | 31 May 2024 | 2022 | Active | ||
| Additional Director | 31 May 2024 | 2020 | Active |
Board colleagues of Josekutty Alumparambil Joseph
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sreerag Jayakrishnan | 10250004 | Jk Clinical Research Services Private Limited , Pharmalectin India Private Limited | Director |
| Thomaskutty Jalumparambil | 08058356 | Alke Research Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Josekutty Alumparambil Joseph
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Josekutty Alumparambil Joseph
Josekutty Alumparambil Joseph currently holds 3 directorships: Jk Clinical Research Services Private Limited (Additional Director, since 31 May 2024); Pharmalectin India Private Limited (Additional Director, since 31 May 2024); Alke Research Private Limited (Additional Director, since 31 May 2024).
Josekutty Alumparambil Joseph was first appointed on 31 May 2024 as Additional Director at Jk Clinical Research Services Private Limited.
The current boards of Josekutty Alumparambil Joseph's companies include Sreerag Jayakrishnan (Jk Clinical Research Services Private Limited), Thomaskutty Jalumparambil (Alke Research Private Limited).